• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fas-FasL相互作用在自身免疫性脱髓鞘疾病发病机制及调控中的作用

Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease.

作者信息

Sabelko-Downes K A, Russell J H, Cross A H

机构信息

Department of Molecular Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

J Neuroimmunol. 1999 Dec;100(1-2):42-52. doi: 10.1016/s0165-5728(99)00191-5.

DOI:10.1016/s0165-5728(99)00191-5
PMID:10695714
Abstract

Multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE) represent complex processes that lead to destruction of oligodendrocytes (ODCs) and myelin. T cells are integral to the development of these diseases, but whether T cell-mediated cytolytic mechanisms are involved in the destruction of MHC Class II-negative targets, such as oligodendroglia and myelin, in the CNS is unclear. The primary lytic mechanism employed by CD4+ T cells is Fas-dependent, but can be MHC-unrestricted. Thus, T cell-mediated Fas-FasL interactions could directly contribute to the pathology of EAE and MS. This review summarizes studies from our laboratory and others that implicate Fas-FasL interactions in both the pathogenesis and regulation of demyelinating diseases.

摘要

多发性硬化症(MS)和实验性自身免疫性脑脊髓炎(EAE)是导致少突胶质细胞(ODC)和髓鞘破坏的复杂过程。T细胞在这些疾病的发展中不可或缺,但T细胞介导的溶细胞机制是否参与中枢神经系统中MHC II类阴性靶标(如少突胶质细胞和髓鞘)的破坏尚不清楚。CD4 + T细胞采用的主要裂解机制是Fas依赖性的,但可以不受MHC限制。因此,T细胞介导的Fas-FasL相互作用可能直接导致EAE和MS的病理变化。这篇综述总结了我们实验室和其他实验室的研究,这些研究表明Fas-FasL相互作用在脱髓鞘疾病的发病机制和调节中都有涉及。

相似文献

1
Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease.Fas-FasL相互作用在自身免疫性脱髓鞘疾病发病机制及调控中的作用
J Neuroimmunol. 1999 Dec;100(1-2):42-52. doi: 10.1016/s0165-5728(99)00191-5.
2
Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.Fas和FasL参与实验性自身免疫性脑脊髓炎发病机制的证据。
Arch Immunol Ther Exp (Warsz). 2000;48(5):381-8.
3
Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis.实验性自身免疫性脑脊髓炎发病机制中Fas依赖和Fas非依赖机制的证据。
J Immunol. 1999 Jun 1;162(11):6392-400.
4
Fas has a crucial role in the progression of experimental autoimmune encephalomyelitis.Fas在实验性自身免疫性脑脊髓炎的进展中起关键作用。
Mol Immunol. 1998 Apr;35(5):317-26. doi: 10.1016/s0161-5890(98)00049-2.
5
Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis.少突胶质细胞通过Fas和TNF-R1凋亡是实验性自身免疫性脑脊髓炎诱导过程中的关键事件。
J Immunol. 2005 Nov 1;175(9):5875-84. doi: 10.4049/jimmunol.175.9.5875.
6
CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.CD28共刺激阻断会加剧疾病严重程度,并加速病毒诱导的自身免疫性疾病中的表位扩展。
J Virol. 2000 Sep;74(18):8349-57. doi: 10.1128/jvi.74.18.8349-8357.2000.
7
Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice.髓鞘少突胶质细胞糖蛋白诱导的自身免疫性脑脊髓炎在穿孔素基因敲除小鼠中呈慢性/复发性,但在Fas和Fas配体缺陷的lpr和gld小鼠中呈单相性。
Eur J Immunol. 1997 Dec;27(12):3151-60. doi: 10.1002/eji.1830271211.
8
Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity.髓鞘特异性 CD8+ T 细胞加剧中枢神经系统自身免疫中的脑炎症。
J Clin Invest. 2020 Jan 2;130(1):203-213. doi: 10.1172/JCI132531.
9
Intrathecal administration of neutralizing antibody against Fas ligand suppresses the progression of experimental autoimmune encephalomyelitis.鞘内注射抗Fas配体中和抗体可抑制实验性自身免疫性脑脊髓炎的进展。
Biochem Biophys Res Commun. 2000 Aug 18;275(1):164-8. doi: 10.1006/bbrc.2000.3279.
10
T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.T细胞受体连接触发新的非凋亡性细胞死亡途径,这些途径不依赖Fas或依赖Fas。
J Immunol. 2002 Dec 1;169(11):6218-30. doi: 10.4049/jimmunol.169.11.6218.

引用本文的文献

1
Pleiotropic Roles of P2X7 in the Central Nervous System.P2X7在中枢神经系统中的多效性作用。
Front Cell Neurosci. 2019 Sep 4;13:401. doi: 10.3389/fncel.2019.00401. eCollection 2019.
2
Genetic determinants of neuronal vulnerability to apoptosis.神经元易凋亡的遗传决定因素。
Cell Mol Life Sci. 2013 Jan;70(1):71-88. doi: 10.1007/s00018-012-1029-y. Epub 2012 Jun 14.
3
Sphingolipids in multiple sclerosis.鞘脂在多发性硬化中的作用。
Neuromolecular Med. 2010 Dec;12(4):351-61. doi: 10.1007/s12017-010-8128-4. Epub 2010 Jul 7.
4
Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.在小鼠模型中,Fas或Fas配体表达异常的淋巴细胞可减轻免疫性骨髓衰竭。
J Immunol. 2009 Mar 15;182(6):3414-22. doi: 10.4049/jimmunol.0801430.
5
Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.自身攻击性(CD4+CD40+)T细胞与调节性(CD4+CD25+FoxP3+)T细胞之间的稳态平衡被破坏会促进糖尿病的发生。
J Leukoc Biol. 2008 Aug;84(2):431-9. doi: 10.1189/jlb.1207857. Epub 2008 May 9.
6
Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients.醋酸格拉替雷可诱导多发性硬化症患者外周淋巴细胞中涉及Bcl-2、Bax和细胞色素c的促凋亡机制。
J Neurol. 2006 Feb;253(2):231-6. doi: 10.1007/s00415-005-0965-y. Epub 2005 Sep 30.
7
Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.在帕金森病1-甲基-4-苯基-1,2,3,6-四氢吡啶模型中Fas对多巴胺能神经元缺失的调控作用
J Neurosci. 2004 Feb 25;24(8):2045-53. doi: 10.1523/JNEUROSCI.4564-03.2004.
8
Cellular FLICE-inhibitory protein: an attractive therapeutic target?细胞FLICE抑制蛋白:一个有吸引力的治疗靶点?
Expert Opin Ther Targets. 2003 Aug;7(4):559-73. doi: 10.1517/14728222.7.4.559.
9
A mitochondrial component of neurodegeneration in multiple sclerosis.多发性硬化症神经退行性变的线粒体成分。
Neuromolecular Med. 2003;3(3):147-58. doi: 10.1385/NMM:3:3:147.
10
Acute disseminated encephalomyelitis.急性播散性脑脊髓炎
Postgrad Med J. 2003 Jan;79(927):11-7. doi: 10.1136/pmj.79.927.11.